Merz Aesthetics Celebrates 15 Years of XEOMIN® (incobotulinumtoxinA) in the U.S. with One Year of Free Treatments Sweepstakes & New Campaign

RALEIGH, N.C.--(BUSINESS WIRE)--Feb 11, 2026--

Merz Aesthetics, the world’s largest dedicated medical aesthetics business, celebrates 15 years since its flagship brand XEOMIN ® was first approved for aesthetic use by the U.S. Food and Drug Administration (FDA). XEOMIN ® is a double-purified neurotoxin, FDA approved for the simultaneous treatment of upper facial lines – forehead lines, frown lines and crow’s feet. To celebrate this 15-year U.S. milestone, 15 lucky winners will receive a year of free XEOMIN ® treatments through Xperience+ by Merz Aesthetics U.S. patient loyalty program.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260211739960/en/

In addition, Merz Aesthetics is also launching a new, refreshed campaign for XEOMIN ® in celebration of the milestone. The new multi-channel initiative—spanning digital platforms to in-office touchpoints—aims to empower patients to ask for XEOMIN ® by showcasing XEOMIN ® ’s natural-looking results that allow people to express themselves.

Containing only three ingredients, XEOMIN ® is the first and only double-purified treatment with XTRACT Technology ®, clinically proven to smooth upper facial lines for natural-looking results 1. XEOMIN ® has a 96% patient satisfaction rate 2,3 and a clinically proven track record of delivering safe, effective, and consistent results. 2,4,5

“Since its debut, XEOMIN ® has been a trusted choice for patients and providers seeking effective, natural-looking results,” said Patrick Urban, President, North America, Merz Aesthetics. “Celebrating 15 years is more than a milestone—it’s a testament to our unwavering commitment to proven performance and advancing aesthetic care.”

With XEOMIN ®, no patients in pivotal clinical studies developed treatment resistance due to neutralizing antibodies. In fact, unnecessary proteins found in some other toxin formulations on the U.S. market may cause an immune response which can lead to a decreased effect and failure of treatment. 6 In a recent survey, just over 1 in 3 toxin users reported to have experienced decreased, or lessening effects, of toxin treatments. 7 XEOMIN ® ’s formulation minimizes this risk and offers a consistent experience, treatment after treatment.

“Leveraging our proprietary XTRACT Technology ® manufacturing process, we have established ourselves as a pioneer in neurotoxins, delivering outcomes and efficacy that both patients and providers expect,” said Dr. Samantha Kerr, Chief Scientific Officer, Merz Aesthetics. “We’re committed to driving continued innovation for years to come.”

To celebrate this U.S. milestone, XEOMIN ® is giving 15 lucky U.S. patients the opportunity to win a free year of XEOMIN ® treatments through Xperience+ by Merz Aesthetics with a participating Xperience+ provider. From February 11 to March 11, 2026, patients are invited to enter HERE and create an account or login to Xperience+ at xperiencemerz.com. No purchase necessary. Full terms and conditions are included in the entry form.

To learn more about XEOMIN ® and locate a local provider, visit XeominAesthetic.com to access the Find a Provider tool. Or sign up for Xperience+ at xperiencemerz.com to receive instant and future rewards on XEOMIN ® and additional Merz Aesthetics treatments.

Keep up with XEOMIN ® on Instagram @XeominAesthetic.

References

About Merz Aesthetics

Merz Aesthetics is a medical aesthetics business with a long history of empowering health care professionals, patients and employees to live every day with confidence. We aim to help people around the world look, feel and live like the best versions of themselves — however they define it. Clinically proven, its product portfolio includes injectables, devices and skin care treatments designed to meet each patient’s needs with high standards of safety and efficacy. Being family owned for more than 115 years, Merz Aesthetics is known for building unique connections with customers who feel like family. Merz Aesthetics ® ’ global headquarters is in Raleigh, N.C., with a commercial presence in 90 countries worldwide. It is also a part of Merz Group, which was founded in 1908 and is based in Frankfurt, Germany. Learn more atus.merzaesthetics.com.

About XEOMIN®(incobotulinumtoxinA)

XEOMIN ® (incobotulinumtoxinA) is a botulinum toxin type A approved by the U.S. Food and Drug Administration (FDA) for the simultaneous treatment of upper facial lines – forehead lines, frown lines and crow’s feet. XEOMIN ® is indicated to temporarily improve the look of moderate to severe upper facial lines. For more information, including Full Prescribing Information and Medication Guide, please visitwww.xeominaesthetic.com. See below for Important Consumer Safety Information.

Head-to-head studies evaluating the relative risk of immunogenicity due to the presence or absence of complexing/unnecessary proteins have not been performed.

XEOMIN ® (incobotulinumtoxinA) IMPORTANT CONSUMER SAFETY INFORMATION

Read the Medication Guide before you start receiving XEOMIN (Zeo-min) and each time XEOMIN is given to you as there may be new information. The risk information provided here is not comprehensive.

To learn more:

Uses: XEOMIN is a prescription medicine that is injected into muscles and used to improve the look of moderate to severe upper facial lines (frown lines, forehead lines, and crow’s feet) in adults for a short period of time (temporary). Please see additional Important Safety Information below and Full Prescribing Information and Medication Guide at XeominAesthetic.com.

Warnings: XEOMIN may cause serious side effects that can be life threatening. Call your doctor or get medical help right away if you have any of these problems anytime (hours to weeks) after treatment with XEOMIN:

These symptoms can happen hours to weeks after you receive an injection of XEOMIN. These problems could make it unsafe for you to drive a car or do other dangerous activities.

Do not use XEOMIN if you are allergic to XEOMIN or any of the ingredients in XEOMIN (see the end of this Guide for a list of ingredients in XEOMIN), had an allergic reaction to any other botulinum toxin products such as rimabotulinumtoxinB (MYOBLOC ® ), onabotulinumtoxinA (BOTOX ®, BOTOX ® COSMETIC), or abobotulinumtoxinA (DYSPORT ® ) or have a skin infection at the planned injection site.

Before receiving XEOMIN, tell your doctor about all of your medical conditions, including if you:

Tell your doctor about all of the medicines you take, including prescription and over-the-counter medicines, vitamins and herbal supplements. Talk to your doctor before you take any new medicines after you receive XEOMIN.

Using XEOMIN with certain other medicines may cause serious side effects. Do not start any new medicines until you have told your doctor that you have received XEOMIN in the past. Especially tell your doctor if you

Ask your doctor if you are not sure if your medicine is one that is listed above. Know the medicines you take. Keep a list of your medicines with you to show your doctor and pharmacist each time you get a new medicine.

Possible Side Effects

XEOMIN can cause serious side effects that can be life threatening including allergic reactions. Symptoms of an allergic reaction to XEOMIN may include: itching, rash, redness, swelling, wheezing, asthma symptoms, or dizziness or feeling faint. Tell your doctor or get medical help right away if you get wheezing or asthma symptoms, or if you get dizzy or faint. See “Warnings.”

The most common side effect of XEOMIN in people with upper facial lines include:

These are not all the possible side effects of XEOMIN. Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit MedWatch or call 1-800-FDA-1088.

General information about the safe and effective use of XEOMIN

Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. You can ask your pharmacist or doctor for information about XEOMIN that is written for health professionals.

Active Ingredient: botulinum toxin type A

Inactive Ingredients: human albumin and sucrose

Copyright © 2026 Merz North America, Inc. All rights reserved

Merz Aesthetics Celebrates 15 Years of XEOMIN® (incobotulinumtoxinA) in the U.S. with One Year of Free Treatments Sweepstakes & New Campaign

PHOENIX (AP) — Candace Parker, Elena Delle Donne, Chamique Holdsclaw and the 1996 U.S. Olympic women's basketball team will be enshrined in the Naismith Memorial Basketball Hall of Fame later this year.

Parker, Holdsclaw and members of the 1996 Olympic team were all in attendance as well as Amar’e Stoudemire and Mike D’Antoni.

They will be joined by longtime NBA official Joey Crawford, NBA coach Doc Rivers and Gonzaga coach Mark Few.

The group was announced at halftime of the women's Final Four with many members in attendance.

Parker won three titles in the WNBA with three teams: Los Angeles, Chicago and Las Vegas. She's the only player in league history to win both the MVP and Rookie of the Year in the same season.

She also won two titles while playing in college for Tennessee under Hall of Fame coach Pat Summitt, two Olympic gold medals and two WNBA MVP awards.

Delle Donne won two league MVP awards in 2015 and 2019, the second of which came when she led the Washington Mystics to their lone WNBA championship. Delle Donne became the first player in league history to shoot over 50% from the field, 40% from behind the 3-point line and 90% from the free throw line.

Holdsclaw won three straight titles at Tennessee from 1996-98, the first team to accomplish that. The 1998 championship was Tennessee’s first undefeated season at 39–0 and the Vols also set an NCAA record for the most wins in a season. Holdsclaw went on to an 11-year WNBA career.

Stoudemire, who was the only NBA player in this year's class, was the NBA Rookie of the Year in 2003 and six-time All-Star. He spent the first eight years of his career with the Phoenix Suns, where he teamed with D'Antoni.

Rivers got nearly 1,200 victories on his resume which puts him eighth on the all-time wins list. He led the Boston Celtics to the NBA championship in 2008 and was also in charge of the Los Angeles Clippers during their Lob City era.

Few has won over 770 games at Gonzaga in his career at the school. He set the NCAA Division I men's coaching record by winning 81 games in his first three years at the school.

Crawford officiated 2,561 regular-season NBA games and 50 Finals games over his 39-year career. He retired in 2016.

The enshrinement ceremony will take place in August at the Hall of Fame in Springfield, Massachusetts.

FILE - Tennessee's Candace Parker (3) passes around North Carolina's La'Tangela Atkinson in the first half of the NCAA college basketball tournament regional final, Tuesday, March 28, 2006, in Cleveland. (AP Photo/Amy Sancetta, File)